Reach Us +441414719275
STAT3 Inhibitory Activity Of Structurally Simplified Withaferin A Analogues | 87808
ISSN: 2150-3494

Chemical Sciences Journal
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Share This Page

STAT3 inhibitory activity of structurally simplified Withaferin A analogues

10TH ANNUAL Chemistry & Mass Spectrometry Congress

Teruyuki Tahara, Ursula Streit, Henry E Pelish and Matthew D Shair

Maruho Co. Ltd, Japan

Posters & Accepted Abstracts: Chem Sci J

DOI: 10.4172/2150-3494-C1-015

Signal Transducer and Activator of Transcription 3 (STAT3) is a component of the JAK/STAT pathway. Therapeutic inhibition of STAT3 has been of high interest, as its aberrant activation has been linked to cancer, inflammation and other human diseases. The withanolide family natural product Withaferin A inhibits STAT3 activation. We designed, synthesized and evaluated simplified withanolide analogues SLW1 and SLW2 and found that SLW1 retained the STAT3 inhibitory activity of Withaferin A.

Teruyuki Tahara has received his Masters in Pharmaceutical Science from Kyoto University in 2005. Currently he is a Medicinal Chemist at Maruho Co. Ltd. His research interests are synthetic organic chemistry, medicinal chemistry and biological evaluation of synthetic molecules. From 2011 to 2015, he was a Visiting Scientist at Harvard University in the Laboratory of Professor Matthew Shair, conducting a joint research project with Maruho. He is currently a PhD student with Prof. Lida at Kinki University.
Email:[email protected]